 |
| JANUARY
9, 2026 |
|
Covering Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- A2
Biotherapeutics: FDA Clearance of IND for
A2B543 for Treatment of Adults With
Recurrent Unresectable, Locally Advanced, or
Metastatic Solid Tumors That Express
Mesothelin and Have Lost HLA-A*02 Expression
More
- Cellares
and City of Hope: To Automate Manufacturing of
Solid Tumor CAR T Cell Therapy More
- Electrome
Corporation: Launches LymeCure Research
Study More
- GoodRx:
Launches RxSmartSaver at Giant Eagle
Pharmacies More
|
|
- As
Biosim Industry Confronts Looming 'Void,' 2026
Marks a Chance to Take Stock and Embrace
Changing Landscape More
- Beta
Bionics: Preliminary, Unaudited Fourth Quarter
2025 Topline Financial Results and Key Metrics
More
- Eledon
Pharmaceuticals: Recent Business Milestones
and 2026 Outlook More
- Fierce
Biotech Fundraising Tracker '26: Parabilis
Pockets $305M; Alveus Emerges With $160M More
- Genelux
Corporation: Pricing of $20.0 Million
Underwritten Public Offering of Common Stock
More
|
|
- BioPharmGuy News: Website Archaeology, Magic
Pills, Sickness is Health, Reverse Food Funnel
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Biotech
Showcase Readies as Biotech Stocks and Deals
Pick Up Podcast
- The
Big4Bio Podcast: Every Moment Matters:
DMPK’s Role in Making Better Drugs and
Better Decisions Podcast
- The
Readout Loud: Ep 383 - JPM to Bring More Deals
and Happy CEOs Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased
by Big4Bio. |
|
|
|
|
|
 |
| Organizational
Leader and Business Strategist
Kyle Kinzie Named President &
Partner |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Biopharmas Axed 47% More
Employees Year Over Year More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- ICYMI: The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What's Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
